CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 27, 2026	Jun. 28, 2025
Income Statement [Abstract]
Net sales	$ 386,667	$ 467,871
Cost of sales	362,730	431,444
Gross profit	23,937	36,427
Research, development and engineering expenses	8,011	9,163
Selling, general and administrative expenses	36,546	26,702
Gain on insurance proceeds, net of losses	(5,904)	0
Total operating expenses	38,653	35,865
Operating income (loss)	(14,716)	562
Interest expense, net	10,074	12,523
Loss before income taxes	(24,790)	(11,961)
Income tax provision (benefit)	23,003	(3,643)
Net loss	$ (47,793)	$ (8,318)
Net loss per share — Basic (in dollars per share)	$ (4.41)	$ (0.77)
Weighted average shares outstanding — Basic (in shares)	10,837	10,762
Net loss per share — Diluted (in dollars per share)	$ (4.41)	$ (0.77)
Weighted average shares outstanding — Diluted (in shares)	10,837	10,762